FDA Drug Recalls

Recalls / Class II

Class IID-0546-2025

Product

Cinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides Pharma Science Ltd. Puducherry, India; Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-885-04

Brand name
Cinacalcet
Generic name
Cinacalcet
Active ingredient
Cinacalcet Hydrochloride
Route
Oral
NDCs
64380-883, 64380-884, 64380-885
FDA application
ANDA209226
Affected lot / code info
Lot #: 7715893A, Exp. Date 12/31/2027

Why it was recalled

Failed Dissolution Specifications.

Recalling firm

Firm
Strides Pharma, Inc.
Manufacturer
Strides Pharma Science Limited
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Ram Ridge Rd, Chestnut Ridge, New York 10977-6714

Distribution

Quantity
6,672 bottles
Distribution pattern
Product was distributed nationwide within the United States

Timeline

Recall initiated
2025-07-09
FDA classified
2025-07-30
Posted by FDA
2025-08-06
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0546-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.